Lidocaine Hydrochloride 2%
This treatment applies to the following species:
LOCAL ANESTHETIC
Lidocaine Hydrochloride 2% Caution
Federal law restricts this drug to use by or on the order of a licensed veterinarian.
For Animal Use Only
KEEP OUT OF REACH OF CHILDREN
Composition
Each mL of sterile aqueous solution contains:
Lidocaine Hydrochloride |
2.0% |
Propylene Glycol |
5.2% |
Sodium Chloride |
0.5% |
Sodium Lactate |
0.5% |
with Methylparaben 0.15%, Sodium Metabisulfite 0.10%, Propylparaben 0.03% and Disodium Edetate 0.001% as preservatives.
Store at controlled room temperature between 15° and 30°C (59° - 86°F).
Lidocaine Hydrochloride 2% Indications
Lidocaine is a potent local anesthetic for producing epidural, nerve conduction and infiltration anesthesia.
Contraindications
Lidocaine is contraindicated in animals with a known hypersensitivity to the drug.
Precautions
Lidocaine is usually well tolerated. Nevertheless, as with all local anesthetics, untoward effects may occur due to hypersensitivity, faulty technique, overdosage and inadvertent intravascular or subarachnoid injection. In case of respiratory arrest, immediate resuscitation with oxygen is indicated.Dosage and Administration
Epidural
Cattle and Horses- 5 to 15 mL.
Dogs and Cats- 1 mL per 10 pounds of body weight.
Nerve Block
Cattle and Horses- 5 to 20 mL.
Infiltration
Dilute to 0.5% concentration (1 mL of 2% solution diluted with 3 mL of sterile water = 4 mL of a 0.5% solution).
Manufactured For VETTEK, Blue Springs, MO 64014
NET CONTENTS: |
NDC |
|
100 mL |
60270-333-10 |
L-2000-04 Rev. 12-03 |
CPN: 1420012.0
100 S.E. MAGELLAN DRIVE, BLUE SPRINGS, MO, 64014
Telephone: | 816-229-9101 | |
Toll-Free: | 800-821-5570 | |
Fax: | 816-224-3080 | |
Email: | info@durvet.com |
![]() |
THIS SERVICE AND DATA ARE PROVIDED "AS IS". DVMetrics assumes no liability, and each user assumes full risk, responsibility, and liability, related to its use of the DVMetrics service and data. See the Terms of Use for further details. |
Copyright © 2025 Animalytix LLC. Updated: 2025-03-02